Soluble and membrane isoforms of Fas/CD95 in fresh adult T-cell leukemia (ATL) cells and ATL-cell lines

International Journal of Cancer

Volumn 72, Issue 1, 1997, Pages 128-132

  Sugahara, Kazuyuki ^a   Yamada, Yasuaki ^a   Hiragata, Youichi ^a   Matsuo, Yuzi ^a   Tsuruda, Kazuto ^a   Tomonaga, Masao ^b   Maeda, Takahiro ^b   Atogami, Sunao ^b   Tsukasaki, Kunihiro ^b   Kamihira, Shimeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; INTERLEUKIN 2 RECEPTOR; LACTATE DEHYDROGENASE; MEMBRANE RECEPTOR; MESSENGER RNA; PROTEIN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; SOUTHERN BLOTTING; T CELL LEUKEMIA;

ANTIGENS, CD95; FLOW CYTOMETRY; HUMANS; LEUKEMIA, T-CELL; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0030788414     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970703)72:1<128::AID-IJC18>3.0.CO;2-F     Document Type: Article

References (21)

1. BLACK, P.H., Shedding from the cell surface of normal and cancer cells. Adv. Cancer Res., 32, 75-199 (1980).
2. CHENG, J., ZHOU, T., LIU, C., SHAPIRO, J.P., BRAUER, M.J., KIEFER, M.C., BARR, P.J. and MOUNTZ, J.P., Protetion from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science, 263, 1759-1762 (1994).
3. DEBATIN, K.M., SUSS, D. and KRAMMER, P.H., Differential expression of APO-1 on human thymocytes: implications for negative selection? Europ. J. Immunol., 24, 753-758 (1994).
4. HEANEY, M.L. and GOLDE, D.W., Soluble cytokine receptors. Blood, 87, 847-857 (1996).
5. ITOH, N., YONEHARA, S., ISHII, A., YONEHARA, M., MIZUSHIMA, S., SAIMESHIMA, M., HASE, A., SETO, Y. and NAGATA, S., The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell, 66, 233-243 (1991).
6. KAMIHIRA, S., ATOGAMI, S., SHODA, H., MOMITA, S., YAMADA, Y. and TOMONAOA, M., Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia. Cancer, 73, 2753-2758 (1994).
7. KAMIHIRA, S., SOHDA, H., ATOGAMI, S., TORIYA, Y., YAMADA, K., TSUKASAKI, S., MOMITA, S., IKEDA, S. and KUSANO, M., Phenotypic diversity and prognosis of adult T-cell leukemia. Leukemia Res., 16, 435-441 (1992).
8. KNIPPING, E., DEBATIN, K.M., STRICKER, K., HEILIG, B., EDER, A. and KRAMMER, P.H., Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. Blood, 85, 1562-1569 (1995).
9. KRAMMER, P.H., BEHRMANN, I., DANIEL, P., DHEIN, J. and DEBATIN, K.M., Regulation of apoptosis in the immune system. Curr. Opin. Immunol., 6, 279-289 (1994).
10. LE DEIST, F., EMILE, J.F., RIEUX-LAUCAT, F., BENKERROU, M., ROBERT, I., BROUSSE, N. and FISCHER, A., Clinical, immunological, and pathological consequences of Fas-deficient conditions. Lancet, 348, 719-723 (1996).
11. OEHM, A., BEHRMANN, I., FALK, W., PAWLITA, M., MAIER, G., KLAS, C., LI-WEBER, M., RICHARDS, S., DHEIN, J. and TRAYTH, B.C., Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem., 267, 10709-10715 (1992).
12. PONCELET, P. and GARAYON, P., Cytofluorometric quantification of cell surface antigen by indirect immunofluorescence using monoclonal antibodies. J. Immunol. Methods. 85, 65-74 (1985).
13. RIEUX-LAUCAT, F., LE DEIST, F., HIVROZ, C., ROBERTS, I.A.G., DEBATIN, K.M., FISCHER, A. and DE VILLARTAY, J.P., Mutations in Fas as associated with human lymphoproliferative syndrome and autoimmunity. Science, 268, 1347-1349 (1995).
14. SHIMOYAMA, M. and MEMBERS OF THE LYMPHOMA STUDY GROUP (1984-87), Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. Brit. J. Haematol., 79, 428-437 (1991).
15. SUDA, T., TAKAHASHI, T., GOLSTEIN, P. and NAGATA, S., Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family, Cell, 75, 1169-1178 (1993).
16. TACHIBANA, O., NAKAZAWA, H., LAMPE, J., WATANABE, K., KLEIHUES, P. and OHGAKI, H., Expression of Fas/Apo-1 during the progression of astrocytomas. Cancer Res., 55, 5528-5530 (1995).
17. WATANABE-FUKUNAGA, R., BRANNAN, C.I., COPELAND, N.G., JENKIN, N.A. and NAGATA, S., Lymphoproliferation disorders in mice explained by defects in Fas antigen that mediates apoptosis. Nature (Lond.), 356, 314-317 (1992).
18. WATSON, M.L., RAO, J.K., GILKSON, G.S., RUIZ, P., EICHER, E.M., PISETSKY, D.S., MATSUZAWA, A., ROCHELLE, J.M. and SELDIN, M.F., Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. exp. Med., 179, 1645-1656 (1992).
19. + ATL cells: induction of CD4 expression. Brit. J. Haematol., 88, 234-241 (1994).
20. YAMADA, Y. OHOMOTO, Y., HATA, T., YAMAMURA, M., MURATA, K., TSUKASAKI, K., KOHNO, T., CHEN, Y., KAMIHIRA, S. and TOMONAGA, M., Features of the cytokines secreted by adult T-cell leukemia (ATL) cells. Leukemia Lymphoma, 21, 443-447 (1996).
21. YONEHARA, S., ISHII, A. and YONEHARA, M., A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. exp. Med., 169, 1747-1756 (1989).